A randomized, open label, single dose, crossover, bioequivalence study of Flecainide 100mg tablet of Vana Darou Gostar Pharm Co., IRAN in comparison of Tambocor 100mg tablet of Meda in 24 healthy adult subjects under fasting condition

Vana Darou Gostar0 个研究点目标入组 48 人开始时间: 待定最近更新: 2021年8月30日

试验速览

暂无简介。

•Aged between 18 - 50 years
•- Body weight between 50 – 100 kg
•- Having good health on the basis of medical history and physical & clinical examination
•- Understand the procedures and give written informed consent

•Subject had undergone surgery of the gastro-intestinal tract
•Subject had donated a unit of blood or participated in another clinical trial, within the last two months before the first treatment.
•Subject had a history of drug or alcohol abuse.
•Subject who smokes more than 10 cigarettes per day.
•Subject had used any prescription medication within 14 days, or any non-prescription medication within 7 days, before the first treatment.

发起方